The present invention relates to medical fluid delivery valves and more particularly to valve assemblies for use with syringes or other medical dispensing devices.
Syringes are commonly used to deliver medications and other biological fluids to a patient. The syringe typically has a plunger which is sealingly engaged with an outer cylindrical chamber to form an inner fluid—receiving chamber. A ‘male’ luer fitting is usually provided at a delivery end of the chamber which receives a female luer fitting with a needle assembly or the like. The fluid channel joining the cavity to the luer fitting is usually open, so that when the needle is removed, the cavity is open to the environment. This is problematic since many medications and biological fluids are sensitive (or can degrade when exposed) to the environment.
It is therefore an object of the present invention to provide a novel valve assembly for use with a syringe or other medical dispensing devices, enabling the latter to be closed to the environment when in an unattached condition.
In one of its aspects, the present invention provides a valve assembly comprising a male luer end portion, a female luer end portion and a channel for the transfer of fluids between the male and female luer end portions, valve means movable between a closed position and an open position, biasing means for biasing the valve means toward the closed position, and actuating means extending into the male luer end portion and coupled to the valve means to actuate the valve means when a female luer end portion of a medical accessory is coupled with the male luer end portion.
In an embodiment the male luer end portion has an inner projection and outer threaded sheath which is spaced therefrom to receive the female luer end portion therebetween. The actuating means includes an actuating member positioned between the outer threaded sheath and the inner projection.
In an embodiment, the valve means includes a valve seat and a valve member moveable relative thereto. The channel includes a first channel portion adjacent the female luer end portion and the inner projection includes a second channel portion. The valve member has a valve channel portion in fluid communication with the first and second channel portions. The valve seat is formed in the second channel portion and the valve member is integrally formed with the female luer end portion.
In one embodiment, the valve member includes an anchor flange extending outwardly toward an inner surface of the housing portion. In this case, the housing portion is coupled to the male luer end portion for movement therewith relative to the valve member. The male luer end portion engages the anchor flange when the valve means is in the closed position and the male luer end portion is spaced from said anchor flange when the valve means is in the open position. The housing portion terminates at an end region adjacent the female luer end portion, the biasing means includes a compression spring located within the housing between the end region and the outer anchor flange.
In another of its aspects, the present invention provides a medical dispensing device comprising a body having a chamber therein to contain a fluid material, a valve assembly in fluid communication with the chamber, the valve assembly having a male coupling member for engaging a female coupling member on a medical accessory to form a fluid coupling between the medical dispensing device and the medical accessory, the valve assembly further comprising flow control means operable to control fluid flow through the male coupling member, the flow control means being operable to be displaced by the female coupling member to open the male coupling member when female coupling member is operatively connected therewith, the flow control means being operable to be displaced by the female coupling member to close the male coupling member when the female coupling member is disconnected therefrom.
In one embodiment, the male coupling member includes an inner male portion and an outer sheath portion spaced therefrom to form a passage there between for receiving the female coupling member, the flow control means including at least one valve actuating portion positioned in the passage to abut the female coupling member and to displace the valve member during the travel of the female coupling member along the passage. The valve assembly includes a valve member and a valve seat, wherein the valve member is positioned against the seat to close the male coupling member. The valve actuating portion includes a pair of abutment elements which are spaced from one another along the passage to receive the female coupling member there between, wherein the pair of abutment elements are operable to travel with the female coupling member along the passage.
In one embodiment, the actuating portion is longitudinally oriented relative to the passage and the abutment elements are positioned along the actuating portion.
The valve member includes a back plate and a plurality of actuating portions equally spaced on the back plate, each of the actuating portions having first and second abutment elements.
In one embodiment, the valve actuating portion includes a locking flange which is adjacent one of the abutment elements. The valve assembly includes a locking seat to receive the locking flange when the male coupling member is in the closed position. The actuating portion has a distal end region, the locking flange being located adjacent the distal end region and the locking seat is formed in the outer sheath portion. The actuating portion is thus arranged to flex in order to displace the locking flange from the locking seat.
In yet another aspect, the present invention provides a medical dispensing device comprising a body having a chamber therein to contain a fluid material, a valve assembly in fluid communication with the chamber, the valve assembly having a male coupling member for engaging a female coupling member on a medical accessory to form a fluid coupling between the medical dispensing device and the medical accessory, the male coupling member including a projection and an outer valve member movable relative to the projection, the projection and the outer valve member forming a fluid channel there between, a sheath portion encircling the projection and spaced therefrom to form a passage to receive the female coupling member, the valve member being engageable with the female coupling member and movable relative to the projection to open the fluid channel when the female coupling member is connected with the male coupling member.
In one embodiment, the valve member forms an outer surface of the male coupling portion.
In an embodiment, biasing means is provided to bias the valve member toward an engaged position with the projection to close the fluid channel. In this particular case, the passage ends at an inner wall and the biasing means includes a spring located between the inner wall and the valve member.
In one embodiment, the projection is fixed to the body and includes an inner passage, the inner passage having one end which is open to the chamber and another end which is open to the fluid channel. The projection also includes an enlarged end portion, the valve member including an outer portion arranged to engage the enlarged end portion to close the fluid channel. In this case the enlarged end portion and the outer end portion on the valve member have mating bevelled surfaces.
In one embodiment, the female coupling member has a leading segment, the valve member being dimensioned to fit within the leading segment.
Preferably, the medical dispensing device includes such items as a syringe, an IV bottle, an IV line, a powder and/or atomized fluid and/or gas inhalant dispenser, an implant delivery dispenser, a ventilator, a syringe pump, an intubation tube, a gastrointestinal feeding tube or a plurality and/or a combination thereof.
Preferably, the medical material is in solid, liquid or gaseous form or a combination thereof and has beneficial properties to enhance life, to promote health, to cure and/or treat a disease, condition or ailment, to monitor and/or indicate a bodily function or a combination thereof. For example, the medical material may be useful for, among others, IV therapy, implantation, stem cell therapy, oncology therapy, blood transfusion and/or organ transplantation.
Several preferred embodiments of the present invention will now be described, by way of example only, with reference to the appended drawings in which:
Referring to the figures, and in particular
In this case, the chamber 20 includes a first male luer end portion 34 adjacent the outlet 26 and the valve unit 14 includes a first female luer end portion 36 which is engageable with the male luer end portion 34. The valve unit 14 also includes a second male luer end portion 38 for coupling with the medical accessory 30.
Although the chamber 20 and the valve unit 14 are separate from one another in this case, it will be understood that they may, alternatively, be integrally formed, for example by combining the first male luer end portion 34 with the female luer end portion 36.
The valve unit 14 has a channel 42 for the transfer of fluids between the female and male luer end portions 36, 38. A valve means, in the form of a valve member 44 is located in the valve unit 14 and is movable between a first position (as shown in
In the embodiment of
The valve member 44 includes an anchor flange 60, and the male luer end portion 38 seats, directly or indirectly, against the anchor flange 60 when the valve is in the closed position as viewed in
The outer housing 58 terminates at a radially inwardly directed end region 62 adjacent the female luer end portion 34 and a biasing means in the form of a compression spring 64 is located within the outer housing between the end region 62 and the anchor flange 60 to bias the valve member toward the first position to close the valve unit.
An alternative arrangement is shown in
The valve member 82 includes a plug portion 92 which is movable relative to and within the second channel portion 78 for engaging the seat portion 90 to close the second channel portion 78. The first channel portion 76 includes a tubular projection 94 extending from the female luer end portion 74. In this case, the valve channel 84 in the valve member 82 is coextensive with the first and second channel portions 76, 78. In this case, the tubular projection 94 is slidably engaged with the valve member 82 within the valve channel 84 and sealed therein by way of seal 98. Likewise, the valve member 84 is sealed within the second channel portion 78 by way of seal 100.
The syringe assembly 10 is used as follows. First, the valve unit 14 is joined to the syringe 12 by engaging the corresponding first male luer end portion 34 with the female luer end portion 36. In this condition, the second male luer end portion 38 is unattached with a medical accessory such as the needle 30 and the actuator 46 is fully extended into the second male luer end portion 38 as shown in
The needle 30 is then attached to the syringe by engaging the female luer end portion on the needle 30 with the second male luer end portion 38. Doing so causes the female luer end portion on the needle 30 to abut and displace the actuating member 46, thereby causing the valve member 44 to be displaced upwardly (as viewed in
Another device is shown at 120
The valve assembly 126 is operable to control fluid flow through the male coupling member 128 and more particularly to be in an open position when the male coupling member 128 is operatively connected with the female coupling member 130 and, conversely, to be in a closed position when the male coupling member 128 is disconnected from the female coupling member 130.
In this case, the body 122 and the valve assembly 126 are integrally formed and, as seen in
The male coupling member 128 includes an inner male portion 140 having an inner fluid channel 140a and an outer sheath portion 142 spaced from the inner male portion 140 to form a passage 144 there between for receiving the female coupling member 130. At least one, in this case three, valve actuating portions 146 (two being shown in
Each valve actuating portion 146 includes a pair of abutment elements 150, 152 which are spaced from one another along the passage 144 to receive the female coupling member 130 there between and to travel with the female coupling member along the passage 144. The abutment element 152 has a bevelled outer surface 152a for reasons to be described. Each actuating portion 146 is longitudinally oriented relative to the passage 144 and the abutment elements 150, 152 are positioned along the actuating portion 146.
Each valve actuating portion 146 includes a locking flange 154 and the valve assembly includes a locking seat 156 to receive the locking flange 154 when the valve member 134 is in the closed position. In this case, the valve actuating portion 146 has a distal end region and the locking flange 154 is located in the distal end region, while the locking seat 156 is formed in the outer sheath portion 142.
It will be seen in
Referring to
The device 120 is thus used as follows. The valve assembly is set with the valve member in its closed position, that is with the valve member 134 in its position against the valve seat 136 as shown in
Referring to
Thus, the device 120 does not make use of a valve member which is biased to its closed position as with the earlier embodiment, but rather relies on the displacement of the female coupling member 130 to draw the valve assembly to its closed position when it is removed from the male coupling member 128.
Another device is shown at 170 in
The valve assembly 176 is operable to control fluid flow through the male coupling member and more particularly to actuate or open the male coupling member 178 when operatively connected with the female coupling member 180 and, conversely, to close the male coupling member 178 when disconnected from the female coupling member 180.
In this case, the male coupling member 178 includes a projection 182 which is fixed to the body 172. A sheath portion 184 encircles the projection 182 and is also fixed to the body 172. The sheath portion 184 and is spaced from the projection 182 to form a passage 186 to receive the female coupling member 180.
A valve member 190 is movable relative to the projection 182 and forms a fluid channel 192 there between and sealed by an inner seal 193. The projection 182 includes an inner passage 194 which has one end 194a open to the chamber 174 and another end 194b which is open to the fluid channel 192.
Referring to
As can be seen in
The valve member 190 is operable to engage the female coupling member 180 and to travel with the female coupling member 180 along the passage 186. In this case, the female coupling member 180 has a leading segment 180a and the outer end portion 200 of the valve member 190 is dimensioned to fit within the leading segment 180a.
In contrast to the device 120 of
While the present invention has been described for what are presently considered the preferred embodiments, the invention is not so limited. To the contrary, the invention is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the appended claims. The scope of the following claims is to be accorded the broadest interpretation so as to encompass all such modifications and equivalent structures and functions.
The valve unit may be used with other medical fluid delivery devices, such as IV lines, catheters, infusion pumps and the like. The valve unit may also be used on syringes and other medical devices which do not employ the ubiquitous luer coupling arrangement.
This application is a continuation of U.S. patent application Ser. No. 14/052,592, filed Oct. 11, 2013, which is a continuation of U.S. patent application Ser. No. 13/305,663, filed Nov. 28, 2011, now U.S. Pat. No. 8,556,868, which is a continuation of U.S. patent application Ser. No. 12/789,255, filed May 27, 2010, now U.S. Pat. No. 8,066,692, which is a continuation of U.S. patent application Ser. No. 10/584,920, filed Dec. 28, 2006, now U.S. Pat. No. 7,758,566, which is the National Stage Entry of International Application No. PCT/US04/42723, filed Dec. 21, 2004, which claims the benefit of U.S. Provisional Application No. 60/532,916, filed Dec. 30, 2003; the entire contents of all of which are hereby incorporated by reference herein and made a part of this specification. Any and all priority claims identified in the Application Data Sheet, or any correction thereto, are hereby incorporated by reference under 37 CFR 1.57.
Number | Name | Date | Kind |
---|---|---|---|
2842382 | Franck | Jul 1958 | A |
2931668 | Baley | Apr 1960 | A |
2968497 | Treleman | Jan 1961 | A |
3127892 | Bellamy, Jr. et al. | Apr 1964 | A |
3304047 | Martin | Feb 1967 | A |
3334860 | Bolton, Jr. | Aug 1967 | A |
3707972 | Villari et al. | Jan 1973 | A |
3729031 | Baldwin | Apr 1973 | A |
3986508 | Barrington | Oct 1976 | A |
4055179 | Mansohot et al. | Oct 1977 | A |
4066067 | Micheli | Jan 1978 | A |
4076285 | Martinez | Feb 1978 | A |
4080965 | Phillips | Mar 1978 | A |
4084606 | Mittleman | Apr 1978 | A |
4121585 | Becker, Jr. | Oct 1978 | A |
4133441 | Mittleman et al. | Jan 1979 | A |
4143853 | Abramson | Mar 1979 | A |
4150845 | Kopacz et al. | Apr 1979 | A |
4195632 | Parker et al. | Apr 1980 | A |
4233982 | Bauer et al. | Nov 1980 | A |
4245635 | Kontos | Jan 1981 | A |
4324239 | Gordon et al. | Apr 1982 | A |
4334551 | Pfister | Jun 1982 | A |
4340049 | Munsch | Jul 1982 | A |
4379458 | Bauer et al. | Apr 1983 | A |
4387879 | Tauschinski | Jun 1983 | A |
4397442 | Larkin | Aug 1983 | A |
4430073 | Bemis et al. | Feb 1984 | A |
4436125 | Blenkush | Mar 1984 | A |
4457749 | Bellotti et al. | Jul 1984 | A |
4511359 | Vaillancourt | Apr 1985 | A |
4538836 | Kruetten | Sep 1985 | A |
4610469 | Wolff-Mooij | Sep 1986 | A |
4619640 | Potolsky et al. | Oct 1986 | A |
4623332 | Lindmayer et al. | Nov 1986 | A |
4629159 | Wellenstam | Dec 1986 | A |
4660803 | Johnston et al. | Apr 1987 | A |
4662878 | Lindmayer | May 1987 | A |
4700744 | Rutter et al. | Oct 1987 | A |
4723603 | Plummer | Feb 1988 | A |
4728075 | Paradis | Mar 1988 | A |
4745950 | Mathieu | May 1988 | A |
4774964 | Bonaldo | Oct 1988 | A |
4774965 | Rodriguez et al. | Oct 1988 | A |
4781702 | Herrli | Nov 1988 | A |
4804015 | Albinsson | Feb 1989 | A |
4816024 | Sitar et al. | Mar 1989 | A |
4819692 | Olson et al. | Apr 1989 | A |
4834271 | Litwin | May 1989 | A |
4862913 | Wildfang | Sep 1989 | A |
4883483 | Lindmayer | Nov 1989 | A |
4915687 | Sivert | Apr 1990 | A |
4917669 | Bonaldo | Apr 1990 | A |
4935010 | Cox et al. | Jun 1990 | A |
4950260 | Bonaldo | Aug 1990 | A |
D313277 | Haining | Dec 1990 | S |
D314050 | Sone | Jan 1991 | S |
5006114 | Rogers et al. | Apr 1991 | A |
5021059 | Kensey et al. | Jun 1991 | A |
5047021 | Utterberg | Sep 1991 | A |
5065783 | Ogle, II | Nov 1991 | A |
5070885 | Bonaldo | Dec 1991 | A |
5098385 | Walsh | Mar 1992 | A |
5108376 | Bonaldo | Apr 1992 | A |
5122123 | Vaillancourt | Jun 1992 | A |
5139483 | Ryan | Aug 1992 | A |
5147333 | Raines | Sep 1992 | A |
5154703 | Bonaldo | Oct 1992 | A |
RE34223 | Bonaldo | Apr 1993 | E |
5199948 | McPhee | Apr 1993 | A |
5201725 | Kling | Apr 1993 | A |
5203775 | Frank et al. | Apr 1993 | A |
5211634 | Vaillancourt | May 1993 | A |
5215537 | Lynn et al. | Jun 1993 | A |
5215538 | Larkin | Jun 1993 | A |
5242393 | Brimhall et al. | Sep 1993 | A |
5242425 | White et al. | Sep 1993 | A |
5251873 | Atkinson et al. | Oct 1993 | A |
5269771 | Thomas et al. | Dec 1993 | A |
5273533 | Bonaldo | Dec 1993 | A |
5279571 | Larkin | Jan 1994 | A |
5281206 | Lopez | Jan 1994 | A |
5284475 | Mackal | Feb 1994 | A |
5295657 | Atkinson | Mar 1994 | A |
5301686 | Newman | Apr 1994 | A |
5306243 | Bonaldo | Apr 1994 | A |
5312377 | Dalton | May 1994 | A |
5324270 | Kayan et al. | Jun 1994 | A |
5330450 | Lopez | Jul 1994 | A |
5334159 | Turkel | Aug 1994 | A |
5344414 | Lopez et al. | Sep 1994 | A |
5360413 | Leason et al. | Nov 1994 | A |
5370636 | Von Witzleben | Dec 1994 | A |
5380306 | Brinon | Jan 1995 | A |
5385372 | Utterberg | Jan 1995 | A |
5390898 | Smedley et al. | Feb 1995 | A |
5391150 | Richmond | Feb 1995 | A |
5395348 | Ryan | Mar 1995 | A |
5397314 | Farley et al. | Mar 1995 | A |
5400500 | Behnke et al. | Mar 1995 | A |
5401245 | Haining | Mar 1995 | A |
5402826 | Molnar et al. | Apr 1995 | A |
5402982 | Atkinson et al. | Apr 1995 | A |
5405323 | Rogers et al. | Apr 1995 | A |
5405331 | Behnke et al. | Apr 1995 | A |
5405333 | Richmond | Apr 1995 | A |
5411499 | Dudar et al. | May 1995 | A |
5417673 | Gordon | May 1995 | A |
5423791 | Bartlett | Jun 1995 | A |
5425465 | Healy | Jun 1995 | A |
5433330 | Yatsko et al. | Jul 1995 | A |
5439451 | Collinson et al. | Aug 1995 | A |
5441487 | Vedder | Aug 1995 | A |
5445623 | Richmond | Aug 1995 | A |
5447177 | Ricken et al. | Sep 1995 | A |
5456668 | Ogle, II | Oct 1995 | A |
5456675 | Wolbring et al. | Oct 1995 | A |
5462255 | Rosen et al. | Oct 1995 | A |
5464399 | Boettger | Nov 1995 | A |
5470319 | Mayer | Nov 1995 | A |
5470327 | Helgren et al. | Nov 1995 | A |
5474536 | Bonaldo | Dec 1995 | A |
5480393 | Bommarito | Jan 1996 | A |
5489274 | Chu et al. | Feb 1996 | A |
5492147 | Challender et al. | Feb 1996 | A |
5501426 | Atkinson et al. | Mar 1996 | A |
5507744 | Tay et al. | Apr 1996 | A |
5514177 | Kurz et al. | May 1996 | A |
5518026 | Benjey | May 1996 | A |
5520665 | Fleetwood | May 1996 | A |
5520666 | Choudhury et al. | May 1996 | A |
5527284 | Ohnemus et al. | Jun 1996 | A |
5533708 | Atkinson et al. | Jul 1996 | A |
5533983 | Haining | Jul 1996 | A |
5533996 | Murphey et al. | Jul 1996 | A |
5535785 | Werge et al. | Jul 1996 | A |
5540661 | Tomisaka et al. | Jul 1996 | A |
5549566 | Elias et al. | Aug 1996 | A |
5549577 | Siegel et al. | Aug 1996 | A |
5549651 | Lynn | Aug 1996 | A |
5552118 | Mayer | Sep 1996 | A |
5555908 | Edwards et al. | Sep 1996 | A |
5569235 | Ross et al. | Oct 1996 | A |
5573516 | Tyner | Nov 1996 | A |
5575769 | Vaillancourt | Nov 1996 | A |
5578059 | Patzer | Nov 1996 | A |
5584819 | Kopfer | Dec 1996 | A |
5591137 | Stevens | Jan 1997 | A |
5591143 | Trombley, III et al. | Jan 1997 | A |
5597536 | Mayer | Jan 1997 | A |
5616129 | Mayer | Apr 1997 | A |
5616130 | Mayer | Apr 1997 | A |
RE35539 | Bonaldo | Jun 1997 | E |
5643224 | Szapiro et al. | Jul 1997 | A |
5645538 | Richmond | Jul 1997 | A |
5674206 | Allton et al. | Oct 1997 | A |
5676346 | Leinsing | Oct 1997 | A |
5685866 | Lopez | Nov 1997 | A |
5685868 | Lundquist | Nov 1997 | A |
5699821 | Paradis | Dec 1997 | A |
5700248 | Lopez | Dec 1997 | A |
5702374 | Johnson | Dec 1997 | A |
5709243 | Wells et al. | Jan 1998 | A |
5735826 | Richmond | Apr 1998 | A |
5738144 | Rogers | Apr 1998 | A |
5749861 | Guala et al. | May 1998 | A |
RE35841 | Frank et al. | Jul 1998 | E |
5782816 | Werschmidt et al. | Jul 1998 | A |
5785693 | Haining | Jul 1998 | A |
5806831 | Paradis | Sep 1998 | A |
5814024 | Thompson et al. | Sep 1998 | A |
5820601 | Mayer | Oct 1998 | A |
5839715 | Leinsing | Nov 1998 | A |
5848994 | Richmond | Dec 1998 | A |
5947954 | Bonaldo | Sep 1999 | A |
6029946 | Doyle | Feb 2000 | A |
6036171 | Weinheimer et al. | Mar 2000 | A |
6039302 | Cote, Sr. et al. | Mar 2000 | A |
6041805 | Gydesen et al. | Mar 2000 | A |
6050978 | Orr et al. | Apr 2000 | A |
6063062 | Paradis | May 2000 | A |
6068011 | Paradis | May 2000 | A |
6068617 | Richmond | May 2000 | A |
6079432 | Paradis | Jun 2000 | A |
6106502 | Richmond | Aug 2000 | A |
6113068 | Ryan | Sep 2000 | A |
6142446 | Leinsing | Nov 2000 | A |
6152913 | Feith et al. | Nov 2000 | A |
6168137 | Paradis | Jan 2001 | B1 |
6170522 | Tanida | Jan 2001 | B1 |
6171287 | Lynn et al. | Jan 2001 | B1 |
6189859 | Rohrbough et al. | Feb 2001 | B1 |
6206860 | Richmond | Mar 2001 | B1 |
6224578 | Davis et al. | May 2001 | B1 |
6242393 | Ishida et al. | Jun 2001 | B1 |
6245048 | Fangrow et al. | Jun 2001 | B1 |
6290206 | Doyle | Sep 2001 | B1 |
6299132 | Weinheimer et al. | Oct 2001 | B1 |
6402207 | Segal et al. | Jun 2002 | B1 |
6428520 | Lopez | Aug 2002 | B1 |
6431219 | Redler et al. | Aug 2002 | B1 |
6485472 | Richmond | Nov 2002 | B1 |
6499719 | Clancy et al. | Dec 2002 | B1 |
6508792 | Szames et al. | Jan 2003 | B2 |
6508807 | Peters | Jan 2003 | B1 |
6541802 | Doyle | Apr 2003 | B2 |
6543745 | Enerson | Apr 2003 | B1 |
6581906 | Pott et al. | Jun 2003 | B2 |
6585229 | Cote et al. | Jul 2003 | B2 |
6595964 | Finley et al. | Jul 2003 | B2 |
6595981 | Huet | Jul 2003 | B2 |
6609696 | Enerson | Aug 2003 | B2 |
6612624 | Segal et al. | Sep 2003 | B1 |
6666852 | Niedospial, Jr. | Dec 2003 | B2 |
6695817 | Fangrow | Feb 2004 | B1 |
6745998 | Doyle | Jun 2004 | B2 |
6808161 | Hishikawa | Oct 2004 | B1 |
6840501 | Doyle | Jan 2005 | B2 |
6869426 | Ganem | Mar 2005 | B2 |
6875205 | Leinsing | Apr 2005 | B2 |
6899315 | Mailville et al. | May 2005 | B2 |
6911025 | Miyahara | Jun 2005 | B2 |
6955669 | Curutcharry | Oct 2005 | B2 |
6964406 | Doyle | Nov 2005 | B2 |
7004934 | Vaillancourt | Feb 2006 | B2 |
7037302 | Vaillancourt | May 2006 | B2 |
7040598 | Raybuck | May 2006 | B2 |
7044441 | Doyle | May 2006 | B2 |
7100891 | Doyle | Sep 2006 | B2 |
7125396 | Leinsing et al. | Oct 2006 | B2 |
7137654 | Segal et al. | Nov 2006 | B2 |
7140592 | Phillips | Nov 2006 | B2 |
7182313 | Doyle | Feb 2007 | B2 |
7195228 | Tiberghien et al. | Mar 2007 | B2 |
7244249 | Leinsing et al. | Jul 2007 | B2 |
7306197 | Perrino et al. | Dec 2007 | B2 |
7306198 | Doyle | Dec 2007 | B2 |
7306566 | Raybuck | Dec 2007 | B2 |
7347458 | Rome et al. | Mar 2008 | B2 |
7350764 | Raybuck | Apr 2008 | B2 |
7361164 | Simpson et al. | Apr 2008 | B2 |
7497484 | Ziman | Mar 2009 | B2 |
7550530 | Korogi et al. | Jul 2009 | B2 |
7588563 | Guala | Sep 2009 | B2 |
7645274 | Whitley | Jan 2010 | B2 |
7651481 | Raybuck | Jan 2010 | B2 |
7666170 | Guala | Feb 2010 | B2 |
7758566 | Simpson et al. | Jul 2010 | B2 |
7766304 | Phillips | Aug 2010 | B2 |
7766897 | Ramsey et al. | Aug 2010 | B2 |
7803139 | Fangrow, Jr. | Sep 2010 | B2 |
7803140 | Fangrow, Jr. | Sep 2010 | B2 |
7815614 | Fangrow, Jr. | Oct 2010 | B2 |
7837658 | Cote et al. | Nov 2010 | B2 |
7857805 | Raines | Dec 2010 | B2 |
7976532 | Kitani et al. | Jul 2011 | B2 |
7998134 | Fangrow et al. | Aug 2011 | B2 |
8066692 | Simpson et al. | Nov 2011 | B2 |
8177772 | Christensen et al. | May 2012 | B2 |
8211069 | Fangrow, Jr. | Jul 2012 | B2 |
8225826 | Horppu et al. | Jul 2012 | B2 |
8262628 | Fangrow, Jr. | Sep 2012 | B2 |
8286936 | Kitani et al. | Oct 2012 | B2 |
8287513 | Ellstrom et al. | Oct 2012 | B2 |
8454579 | Fangrow, Jr. | Jun 2013 | B2 |
8556868 | Simpson et al. | Oct 2013 | B2 |
8721628 | Ziman | May 2014 | B2 |
8777908 | Fangrow, Jr. | Jul 2014 | B2 |
8777909 | Fangrow, Jr. | Jul 2014 | B2 |
8888758 | Mansour et al. | Nov 2014 | B2 |
9114242 | Fangrow et al. | Aug 2015 | B2 |
9126028 | Fangrow et al. | Sep 2015 | B2 |
9126029 | Fangrow et al. | Sep 2015 | B2 |
9168366 | Fangrow et al. | Oct 2015 | B2 |
9345641 | Krause et al. | May 2016 | B2 |
9358379 | Fangrow | Jun 2016 | B2 |
9592344 | Simpson et al. | Mar 2017 | B2 |
9707346 | Simpson et al. | Jul 2017 | B2 |
20020066715 | Niedospial, Jr. | Jun 2002 | A1 |
20030066978 | Enerson | Apr 2003 | A1 |
20030136932 | Doyle | Jul 2003 | A1 |
20030208165 | Christensen et al. | Nov 2003 | A1 |
20040074541 | Sharpe | Apr 2004 | A1 |
20040124388 | Kiehne | Jul 2004 | A1 |
20040124389 | Phillips | Jul 2004 | A1 |
20040244848 | Maldavs | Dec 2004 | A1 |
20050015075 | Wright et al. | Jan 2005 | A1 |
20050124942 | Richmond | Jun 2005 | A1 |
20050228362 | Vaillancourt | Oct 2005 | A1 |
20060025751 | Roy et al. | Feb 2006 | A1 |
20060058734 | Phillips | Mar 2006 | A1 |
20060065873 | Doyle | Mar 2006 | A1 |
20060129109 | Shaw et al. | Jun 2006 | A1 |
20060142730 | Proulx et al. | Jun 2006 | A1 |
20060142735 | Whitley | Jun 2006 | A1 |
20060149213 | Raybuck | Jul 2006 | A1 |
20060157984 | Rome et al. | Jul 2006 | A1 |
20060161115 | Fangrow | Jul 2006 | A1 |
20060202146 | Doyle | Sep 2006 | A1 |
20060253084 | Nordgren | Nov 2006 | A1 |
20070043334 | Guala | Feb 2007 | A1 |
20070088292 | Fangrow | Apr 2007 | A1 |
20070088293 | Fangrow | Apr 2007 | A1 |
20070088294 | Fangrow | Apr 2007 | A1 |
20070088327 | Guala | Apr 2007 | A1 |
20070102923 | Niemela | May 2007 | A1 |
20070179453 | Lim et al. | Aug 2007 | A1 |
20080103485 | Kruger | May 2008 | A1 |
20080190485 | Guala | Aug 2008 | A1 |
20080290657 | McKeon, III | Nov 2008 | A1 |
20090177170 | Kitani et al. | Jul 2009 | A1 |
20100063482 | Mansour et al. | Mar 2010 | A1 |
20100174242 | Anderson et al. | Jul 2010 | A1 |
20100253070 | Cheon et al. | Oct 2010 | A1 |
20110306931 | Kamen et al. | Dec 2011 | A1 |
20120031515 | Whitaker | Feb 2012 | A1 |
20120089101 | Carlyon et al. | Apr 2012 | A1 |
20120316536 | Carrez et al. | Dec 2012 | A1 |
20130035668 | Kitani et al. | Feb 2013 | A1 |
20130317483 | Reichart et al. | Nov 2013 | A1 |
20150051555 | Fangrow, Jr. | Feb 2015 | A1 |
20160213910 | Fangrow, Jr. et al. | Jul 2016 | A1 |
20160263367 | Fangrow et al. | Sep 2016 | A1 |
20170296801 | Fangrow, Jr. | Oct 2017 | A1 |
Number | Date | Country |
---|---|---|
2747283 | Jul 2002 | CA |
0 158 030 | Oct 1985 | EP |
0 368 473 | May 1990 | EP |
0 791 371 | Aug 1997 | EP |
0 795 342 | Sep 1997 | EP |
1 946 792 | Jul 2008 | EP |
2 116 277 | Sep 1983 | GB |
2 118 440 | Nov 1983 | GB |
2 353 078 | Feb 2001 | GB |
56-72659 | Jun 1981 | JP |
58-13216 | Jan 1983 | JP |
59-41429 | Mar 1984 | JP |
60-89488 | Jun 1985 | JP |
63-175383 | Nov 1988 | JP |
11-311234 | Nov 1999 | JP |
2001-187990 | Jul 2001 | JP |
2004-000483 | Jan 2004 | JP |
WO 199532748 | Dec 1995 | WO |
WO 200103756 | Jan 2001 | WO |
WO 200123026 | Apr 2001 | WO |
WO 2002096500 | Dec 2002 | WO |
WO 2003013646 | Feb 2003 | WO |
WO 2004060474 | Jul 2004 | WO |
WO 2004082756 | Sep 2004 | WO |
WO 2006076656 | Jul 2006 | WO |
WO 2006088858 | Aug 2006 | WO |
WO 2006124756 | Nov 2006 | WO |
WO 2007008511 | Jan 2007 | WO |
WO 2007112944 | Oct 2007 | WO |
WO 2008144447 | Nov 2008 | WO |
WO 2010071848 | Jun 2010 | WO |
WO 2011139995 | Nov 2011 | WO |
WO 2013036854 | Mar 2013 | WO |
Entry |
---|
U.S. Appl. No. 15/499,740, filed Apr. 27, 2017, Fangrow. |
U.S. Appl. No. 14/020,579, filed Oct. 22, 2015, Fangrow et al. |
Air Embolism and Exsanguination from Separation of Two-Piece Side Port/Hemostasis Valve Cardiac Catheter Introducers, ECRI Institute, Jan. 1995, in 2 pages, http://www.mdsr.ecri.org/summary/detail.aspx?doc_id=8098. |
Injection Site, Molded Products, Inc., Apr. 2, 2004, in 1 page, https://web.archive.org/web/20040402123354/https://www.moldedproducts.com/injectionsite.htm. |
EPO Search Report re EP Application No. 08 755 612.2, dated Feb. 23, 2012 in 5 pages. |
EPO Examination Report re EP Application No. 08 755 612.2, dated Nov. 20, 2013 in 5 pages. |
EPO Examination Report re EP Application No. 08 755 612.2, dated Dec. 5, 2012 in 6 pages. |
International Search Report for PCT/US2006/026124, dated Mar. 3, 2007 in 5 pgs. |
International WrittenOpinion for PCT/US2006/026124, dated Jan. 10, 2008 in 11 pgs. |
International Search Report and Written Opinion of International Application No. PCT/US2008/063797 dated Dec. 30, 2008 in 21 pages. |
International Preliminary Report on Patentability, International Application No. PCT/US2008/063797 dated Nov. 17, 2009 in 11 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2004/042723, dated Jun. 28, 2005 in 16 pages. |
International Written Opinion of International Application No. PCT/US2004/042723 dated Jul. 3, 2006 in 10 pages. |
U.S. Appl. No. 15/789,242, filed Oct. 20, 2016, Fangrow, Jr. et al. |
ICU Medical, Inc. U.S. Appl. No. 11/417,648, filed May 3, 2006. |
ICU Medical, Inc. U.S. Appl. No. 11/417,671, filed May 3, 2006. |
ICU Medical, Inc. U.S. Appl. No. 11/417,882, filed May 3, 2006. |
ICU Medical, Inc. U.S. Appl. No. 11/417,909, filed May 3, 2006. |
ICU Medical, Inc. U.S. Appl. No. 11/417,923, filed May 3, 2006. |
ICU Medical, Inc. U.S. Appl. No. 15/789,242, filed Oct. 20, 2016. |
Number | Date | Country | |
---|---|---|---|
20170304547 A1 | Oct 2017 | US |
Number | Date | Country | |
---|---|---|---|
60532916 | Dec 2003 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14052592 | Oct 2013 | US |
Child | 15648147 | US | |
Parent | 13305663 | Nov 2011 | US |
Child | 14052592 | US | |
Parent | 12789255 | May 2010 | US |
Child | 13305663 | US | |
Parent | 10584920 | US | |
Child | 12789255 | US |